- Home
- CELC vs CAKE Comparison
CELC vs CAKE Comparison
Compare CELC & CAKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- CAKE
- Stock Information
- Founded
- CELC 2011
- CAKE 1972
- Country
- CELC United States
- CAKE United States
- Employees
- CELC N/A
- CAKE N/A
- Industry
- CELC Medical Specialities
- CAKE Restaurants
- Sector
- CELC Health Care
- CAKE Consumer Discretionary
- Exchange
- CELC Nasdaq
- CAKE Nasdaq
- Market Cap
- CELC 2.3B
- CAKE 2.7B
- IPO Year
- CELC 2017
- CAKE 1992
- Fundamental
- Price
- CELC $51.88
- CAKE $54.00
- Analyst Decision
- CELC Strong Buy
- CAKE Hold
- Analyst Count
- CELC 5
- CAKE 14
- Target Price
- CELC $67.20
- CAKE $61.00
- AVG Volume (30 Days)
- CELC 1.1M
- CAKE 1.1M
- Earning Date
- CELC 11-13-2025
- CAKE 10-28-2025
- Dividend Yield
- CELC N/A
- CAKE 2.00%
- EPS Growth
- CELC N/A
- CAKE 35.29
- EPS
- CELC N/A
- CAKE 3.24
- Revenue
- CELC N/A
- CAKE $3,669,456,000.00
- Revenue This Year
- CELC N/A
- CAKE $7.24
- Revenue Next Year
- CELC N/A
- CAKE $6.07
- P/E Ratio
- CELC N/A
- CAKE $16.66
- Revenue Growth
- CELC N/A
- CAKE 4.77
- 52 Week Low
- CELC $7.58
- CAKE $40.72
- 52 Week High
- CELC $63.06
- CAKE $69.70
- Technical
- Relative Strength Index (RSI)
- CELC 53.91
- CAKE 41.89
- Support Level
- CELC $45.15
- CAKE $51.80
- Resistance Level
- CELC $50.00
- CAKE $55.28
- Average True Range (ATR)
- CELC 3.48
- CAKE 1.38
- MACD
- CELC -0.04
- CAKE 0.25
- Stochastic Oscillator
- CELC 64.67
- CAKE 51.41
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About CAKE Cheesecake Factory Incorporated (The)
Cheesecake Factory Inc owns and operates restaurants in the United States and Canada under brands that include The Cheesecake Factory, North Italia, and a collection within the Fox Restaurants Concepts subsidiary. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, other FRC, and Flower Child. Majority of the company's revenue comes from The Cheesecake Factory restaurants segment.